Kevin Litchfield
@kevlitchfield
Research Leader @IsomorphicLabs and honorary Group Leader at UCL Cancer Institute
ID:1457793146
https://scholar.google.co.uk/citations?user=jMPt91EAAAAJ&hl=en 25-05-2013 18:57:35
311 Tweets
1,1K Followers
1,6K Following
We are recruiting a Research Scientist in Computational Biology Isomorphic Labs - building on the latest AI models #AlphaFold and beyond to redefine drug discovery. A hugely exciting time! boards.greenhouse.io/isomorphiclabs…
(Part of) the Centre for cancer genomics and computational biology Barts Cancer Institute (Queen Mary) attending one of Bart’s iconic Christmas parties! Happy holiday season from us! 🎉🎈🍾
We are happy to share our latest review and views on the key role that FcRs play impacting the in vivo activity of immune modulatory antibodies in cancer. Full text rdcu.be/ds0Vz
Well done Quezada Lab Kevin Litchfield teams!
nature.com/articles/s4156…
Meet our #MakingDataFAIR webinar speakers below 👇
Learn how to apply FAIR principles to your research from academic + commercial perspective at 1-2pm next Monday: bit.ly/3Qi8bHg
Kevin Litchfield | The Crick | Cancer Research Horizons | Katarzyna Kamieniecka | ELIXIR UK
#CRUKDataSeries
Stimulating talk by Kevin Litchfield UCL Cancer Institute on using the results from TRACERx lung to inform the development of a preventative cancer vaccine in non-small cell lung cancer
#OxPPSymp23
We’ll be at #ELRIGDD23 at Booth F10 on 18 October!
Don't miss Kevin Litchfield’s (@UCL) talk on immuno-oncology therapeutic discovery at 15.45 🧑🔬
We look forward to seeing you there - visit us to find out about our #DrugDiscovery research.
Register here: elrig.eventsair.com/dd23/
Immunotherapy: Purpose, Resistance, and Toxicity—
Toni K. Choueiri, Valentina Hoyos Velez, Sherene Loi, and Kevin Litchfield will address this topic in a State-of-the-Art session at #SABCS23 . Learn more:
bit.ly/3DMxlYt
Toni Choueiri, MD Valentina Hoyos Velez, MD Sherene Loi, MD Kevin Litchfield
Read the paper featured on the cover—
Late-stage #melanoma : A diversity of evolutionary pathways, by Lavinia Spain, Alexander Coulton, Irene, Andrew Rowan, Desiree Schnidrig Kevin Litchfield, Charles Swanton, Mariam Jamal-Hanjani, Turajlic Lab @ The Crick et al.
bit.ly/43pJhdZ
The Crick
By👩🔬: Y. Chu, E. Dai, Y. Li, Guangchun Han, G. Pei, D. R. Ingram,... Charles Swanton, X.-D. Cheng, Hussein Abbas, M. Gillison, K. Bhat, AlexanderLazarMDPhD, Michael Green, PhD, Kevin Litchfield, Humam Kadara, Cassian Yee, Linghua Wang, MD, PhD.
Nature Medicine MD Anderson Cancer Center
nature.com/articles/s4159…
1/15 🧵 I'm thrilled to share the fantastic news that our Pan-Cancer T cell Atlas is now live Nature Medicine nature.com/articles/s4159… MD Anderson Cancer Center #SingleCell #SpatialOmics #TumorMicroenvironment #CancerImmunotherapy
Here's our The Lancet Oncology Policy Review! Please RT🙏
Defining the roadmap to a UK national #lungcancer #screening programme #TLHC authors.elsevier.com/a/1h0Qb5EIIgLp…
Such a fab community. Dedicated, wise, friendly. Pleasure to write with. Bring on full roll-out! BTOG Roy Castle Lung Cancer Foundation
Our latest paper in Nature Communications uncovers a breakthrough in the understanding of motor neuron death in ALS!
nature.com/articles/s4146…
A thread 🧵 (1/12)
💥Very excited to share our latest work in Cancer Cell harmonizing WES/RNAseq from melanoma IO datasets to better understand predictors of response to anti-PD-1 therapy. Thank you Parker Institute for Cancer Immunotherapy Science At BMS for supporting this herculean effort in data assembly and analysis
Today our important study on air pollutants in the promotion of lung cancer has been published in nature led by Will Hill Emilia Lim Clare Weeden Swanton Lab ...Thread below🧵nature.com/articles/s4158…
Excellent seminar by Eugene Manley, Jr., Ph.D. about STEM outreach, Health Equity and Mentoring Programs in Lung Cancer UCL Cancer Institute. Eugene spoke about community engagement, underserved communities, and workforce EDI initiatives in his talk. Thanks to Mariam Jamal-Hanjani and Kevin Litchfield